Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer
Status:
Completed
Trial end date:
2000-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemosensitizers may increase the effectiveness of a chemotherapy drug by making
tumor cells more sensitive to the drug.
PURPOSE: Randomized phase III trial to study the effectiveness of chemosensitivity testing to
assign treatment for patients with stage III or stage IV ovarian cancer who have undergone
surgery.